[1]
|
García-García, P.M., Getino-Melián, M.A., Dominguez-Pimentel, V. and Navarro-González, J.F. (2014) Inflammation in Diabetic Kidney Disease. World Journal of Diabetes, 5, 431-443. https://doi.org/10.4239/wjd.v5.i4.431
|
[2]
|
Donate-Correa, J., Martín-Nuñez, E., Muros-de-Fuentes, M., Mo-ra-Fernández, C. and Navarro-González, J.F. (2015) Inflammatory Cytokines in Diabetic Nephropathy. Journal of Diabetes Research, 2015, Article ID: 948417.
https://doi.org/10.1155/2015/948417
|
[3]
|
Rayego-Mateos, S., Morgado-Pascual, J.L., Opazo-Ríos, L., et al. (2020) Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy. International Journal of Molecular Sciences, 21, Article No. 3798. https://doi.org/10.3390/ijms21113798
|
[4]
|
Navarro-González, J. and Mora-Fernández, C. (2008) The Role of Inflammatory Cytokines in Diabetic Nephropathy. Journal of the American Society of Nephrology, 19, 433-442. https://doi.org/10.1681/ASN.2007091048
|
[5]
|
Navarro-González, J., Mora-Fernández, C., de Fuentes, M. and García-Pérez, J. (2011) Inflammatory Molecules and Pathways in the Pathogenesis of Diabetic Nephropathyy. Nature Reviews Nephrology, 7, 327-340.
https://doi.org/10.1038/nrneph.2011.51
|
[6]
|
Milas, O., Gadalean, F., Vlad, A., et al. (2020) Pro-Inflammatory Cytokines Are Associated with Podocyte Damage and Proximal Tubular Dysfunction in the Early Stage of Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients. Journal of Diabetes and Its Complications, 34, Article ID: 107479. https://doi.org/10.1016/j.jdiacomp.2019.107479
|
[7]
|
L,i Y., Hu, Q., Li, C., et al. (2019) PTEN-Induced Partial Epithelial-Mesenchymal Transition Drives Diabetic Kidney Disease. Journal of Clinical Investigation, 129, 1129-1151. https://doi.org/10.1172/JCI121987
|
[8]
|
Das, N.A., Carpenter, A.J., Belenchia, A., et al. (2020) Empagliflozin Reduces High Glucose-Induced Oxidative Stress and miR-21-Dependent TRAF3IP2 Induction and RECK Suppression, and Inhibits Human Renal Proximal Tubular Epithelial Cell Migration and Epithelial-to-Mesenchymal Transition. Cellular Signalling, 68, Article ID: 109506.
https://doi.org/10.1016/j.cellsig.2019.109506
|
[9]
|
Ruster, C. and Wolf, G. (2008) The Role of Chemokines and Chemokine Receptors in Diabetic Nephropathy. Frontiers in Bioscience, 13, 944-955. https://doi.org/10.2741/2734
|
[10]
|
张效丽, 周吉, 阴永辉. 芪归药对治疗糖尿病肾病疗效及对Nrf2通路的影响[J]. 山东中医杂志, 2020, 39(9): 944-949.
|
[11]
|
Kong, C., Chen, D.F., Song, Z.H., et al. (2018) Exploration of Treating Diabetic Nephropathy with Astragalus and Angelica. Liaoning Journal of Traditional Chinese Medicine, 45, 267-269.
|
[12]
|
谢毅强, 尹德辉, 黄凌, 朱叶, 刘嫱. 一种用于治疗糖尿病肾病的中药组合物、中药制剂及其制备方法[P]. 中国专利, CN105878894A, 2016-08-24.
|
[13]
|
尹德辉, 朱叶, 倪雅丽, 姚宇剑, 林丹, 谢毅强. 缩泉益肾方治疗2型糖尿病肾病的临床疗效[J]. 中国老年学杂志, 2019, 39(9): 2091-2092.
|
[14]
|
Zhang, J., Jiang, T., Liang, X., et al. (2019) LncRNA MALAT1 Mediated High Glucose-Induced K-2 Cell Epithelial-to-Mesenchymal Transition and Injury. Journal of Physiology and Biochemistry, 75, 443-452.
https://doi.org/10.1007/s13105-019-00688-2
|
[15]
|
Zhang, J., Zhang, Q., Lou, Y., et al. (2018) Hypoxia-Inducible Factor-1α/Interleukin-1β Signaling Enhances Hepatoma Epithelial-Mesenchymal Transition through Macrophages in a Hypoxic-Inflammatory Microenvironment. Hepatology, 67, 1872-1889. https://doi.org/10.1002/hep.29681
|
[16]
|
张铭晖. 糖尿病肾病患者血清脂联素、脂蛋白A和白介素6水平变化及意义[J]. 河北医药, 2019, 41(17): 2642-2645.
|
[17]
|
张翠平. 血清OPG、TNF-α、IL-6水平与糖尿病肾病的关系[J]. 检验医学与临床, 2022, 19(2): 189-192.
|
[18]
|
Tang, S.C.W. and Yiu, W.H. (2020) Innate Immunity in Diabetic Kidney Disease. Nature Reviews Nephrology, 16, 206-222. https://doi.org/10.1038/s41581-019-0234-4
|
[19]
|
Wellen, K.E. and Hotamisligil, G.S. (2005) Inflammation, Stress, and Diabetes. Journal of Clinical Investigation, 115, 1111-1119. https://doi.org/10.1172/JCI25102
|
[20]
|
Matoba, K., Takeda, Y., Nagai, Y., Kawanami, D., Utsunomiya, K. and Nishimura, R. (2019) Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease. International Journal of Molecular Sciences, 20, Article No. 3393. https://doi.org/10.3390/ijms20143393
|
[21]
|
Pérez-Morales, R.E., Del Pino, M.D., Valdivielso, J.M., Ortiz, A., Mora-Fernández, C. and Navarro-González, J.F. (2019) Inflammation in Diabetic Kidney Disease. Nephron, 143, 12-16. https://doi.org/10.1159/000493278
|
[22]
|
Panchapakesan, U., Pegg, K., Gross, S., et al. (2013) Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells—Renoprotection in Diabetic Nephropathy? PLOS ONE, 8, e54442.
https://doi.org/10.1371/journal.pone.0054442
|
[23]
|
Zhu, Y., Cui, H., Xia, Y. and Gan, H. (2016) RIPK3-Mediated Necroptosis and Apoptosis Contributes to Renal Tubular Cell Progressive Loss and Chronic Kidney Disease Progression in Rats. PLOS ONE, 11, e0156729.
https://doi.org/10.1371/journal.pone.0156729
|
[24]
|
Lv, L., Zhang, J., Tian, F., Li, X., Li, D. and Yu, X. (2019) Arbutin Protects HK-2 Cells against High Glucose-Induced Apoptosis and Autophagy by up-Regulating micro-RNA-27a. Artificial Cells, Nanomedicine, and Biotechnology, 47, 2940-2947. https://doi.org/10.1080/21691401.2019.1640231
|
[25]
|
倪雅丽, 姚宇剑, 汤灿, 等. 缩泉益肾方与益智仁对糖尿病肾脏疾病小鼠疗效及肠道菌群的影响差异研究[J]. 海南医学院学报, 2021, 27(11): 820-826. https://doi.org/10.13210/j.cnki.jhmu.20210104.002
|
[26]
|
尹德辉, 朱叶, 吴珠, 等. 缩泉益肾方对糖尿病肾脏疾病患者的血清炎症因子及肾功能的影响[J]. 时珍国医国药, 2021, 32(8): 1931-1933.
|